A phase 2 asthma study of Upstream Bio’s TSLP receptor antagonist has hit its primary endpoint. But, with only the 12-week regimen achieving a Tezspire-like reduction in the annualized asthma ...
GlobalWafers opened $3.5 bln Texas plant last year Chairwoman upbeat on Taiwan-US trade deal Company is a major supplier to TSMC HSINCHU, Taiwan, Jan 21 (Reuters) - Taiwanese silicon wafer ...
A Metropolitan Transportation Authority rendering shows a conceptual interior of a future Second Avenue Subway station in Harlem, illustrating platform circulation, train clearances and passenger flow ...
Fans will be able to apply for single-match tickets based on exact match-ups and teams for group-stage games. High demand continues as the Early Ticket Draw sees inventory snatched up by fans in more ...
Johnson & Johnson’s attempt to develop a $5 billion-a-year Alzheimer’s disease drug has been rocked by a phase 2 flop. A scheduled data review found the anti-tau antibody posdinemab failed to ...
To fulfill the 2 Core Courses, take two Core Courses from two different Core Areas. CSE Core Courses are classified into six areas: Introduction to CSE, Computational Mathematics, High Performance ...
After years of technical analysis, public input and federal review, the Santa Clara Valley Transportation Authority (VTA) recently selected the single-bore tunnel as the preferred design method for ...
The biggest stories of the day delivered to your inbox.
U.S. President Donald Trump said on Sunday he is ready to move to a second phase of sanctioning Russia, the closest he has come to suggesting he is on the verge of ramping up sanctions against Moscow ...
HARLEM, Manhattan (WABC) -- The next phase of the Second Avenue subway is finally moving forward -- 50 years after the project came to a halt. The nearly $2 billion deal includes boring a new tunnel, ...
Schrödinger has halted development of its cancer-fighting candidate SGR-2921 after two patients treated with the cell division cycle 7 (CDC7) inhibitor died in a Phase I trial. The trial (NCT05961839) ...